At the start of 2020, as the world was coming to grips with what was then known as the novel coronavirus, software developer Colin Hickey decided he needed to act.
The coronavirus pandemic has put enormous strain on everything from hospital capacity to global supply chains and manufacturing. It also spurred a flurry of activity around vaccine development and medical manufacturing as governments, health experts and big business realised the world needed solutions to the crisis, and quickly.
Examin COVID breath test - A breath-testing device with a biosensor that can detect virus particles and produce results within minutes. The device is designed to be simple to use and would be useful for testing in GP clinics. In clinical trials. Working prototypes of Mr Hickey’s Examin breath test device have already gone through initial human trials in Malaysia and a full clinical trial in Singapore is set to begin by the end of the month. Next comes all the regulatory hoops, with mountains of paperwork that must be completed before the devices can be distributed at scale.
The Vaxxas vaccine device, currently in phase one clinical trials, is a small patch covered in minuscule projections coated with vaccine powder, which is flicked onto the arm. While it sounds simple, Mr Junger said the team had to develop several bespoke technologies to produce it.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: SkyNewsAust - 🏆 7. / 78 Read more »